MEDICAL DEVICES

Extremity Medical Files Patent Infringement Lawsuit Against Nextremity Solutions, Zimmer Biomet Holdings and Zimmer, Inc.

Extremity Medical, LLC | April 07, 2022

Extremity Medical

Extremity Medical, LLC, a global medical device company focused on the development of innovative implants and instruments for upper and lower extremities, announced  that it filed a lawsuit against Nextremity Solutions, Inc.; Zimmer Biomet Holdings, Inc.; and Zimmer, Inc., alleging infringement of an Extremity Medical patent* for its intraosseous fixation platform arising from the marketing of the InCore® Lapidus System by these companies. The complaint was filed in the U.S. District Court for the District of Delaware.

Extremity Medical has amassed an intellectual property portfolio that includes 49 patents in the U.S. and several foreign countries. The novel and patented technology of Extremity’s intraosseous fixation platform provides surgeons with a zero-profile solution for fusion and fixation of bones within the upper and lower extremities, with the ability to be implanted through minimal incisions. This technology is currently marketed globally by Extremity under the trade names IO FiX, IO FiX Plus, IO FiX 2.0, IO Freedom, CarpalFiX, ApeX and XMCP.

Extremity Medical has invested a tremendous amount of effort and resources in research and development to create innovative technology to improve the lives of patients and meet surgeons’ needs. Our intellectual property is a critical component in making such advancements possible and we are committed to protecting it,”

Matthew Lyons, Extremity Medical Chief Executive Officer, Founder and Chairman of the Board

 

About Extremity Medical, LLC

Extremity Medical, was founded in 2008, and is a privately-held medical device company based in Parsippany, NJ. The company is known for creating innovative implants and instruments for upper and lower extremity orthopedic procedures, including fusion and motion preservation. The company is focused on developing solutions for challenging cases that promote better outcomes, especially in patients with poor bone quality.

Spotlight

In the last decade, research confirmed that low health literacy has negative effects. It is associated with poor chronic disease management, poor comprehension and adherence to medication regimes, increased hospitalization and poor outcomes.

Spotlight

In the last decade, research confirmed that low health literacy has negative effects. It is associated with poor chronic disease management, poor comprehension and adherence to medication regimes, increased hospitalization and poor outcomes.

Related News

HEALTH TECHNOLOGY

MedSec Sets Up a Healthcare Technology Cyber Risk Management Team

MedSec | July 04, 2022

In order to increase its biological and clinical knowledge, MedSec, a premier solutions provider of medical device security, announced it is forming a new Healthcare Technology Cyber Risk Management (HTCRM) team with a roster of seasoned professionals in the sector. The present Chief Product Officer of MedSec and HTCRM authority Phil Englert will take on the position of Advisor for the new team. "MedSec serves stakeholders of all kinds within the medical device eco-system. The establishment of this team allows us to better serve our hospital clients, who are tackling medical device security on a day-to-day basis." Justine Bone, CEO at MedSec "Biomedical and Clinical Engineering teams already have too many things on their plate – and they need leverage. Becoming an extension of their team, augmented by our technology capabilities, we're able to help our customers do things that they would otherwise not be capable of doing with their existing staff. Our clients love the combination of being able to 'speak tech' but also 'understand clinical' to help them further achieve their goals." Andrew Donarumo, Chief Technology Officer at MedSec Englert will continue to assist MedSec in creating security options for hospitals as an advisor. Englert brings to the position extensive understanding of clinical settings and medical technologies. His experience covers more than 30 years of technical and operational leadership in the healthcare and life sciences sector with an emphasis on creating strategic direction, enhancing operations, and undertaking business optimization and transformation efforts that are enabled by data and technology. In addition to governance and operations, vulnerability and patch management, incident response, medical device alerts, and SOC integration, Phil has led the development of medical device security programmes that have made it possible to prioritise strategic initiatives that will have an impact and carry out efficient maintenance and response tasks. In the past, he oversaw the development of strategy and tactics for a $250 million MedTech services business that supported over 130 Acute Care hospitals in 22 states.

Read More

FUTURE OF HEALTHCARE

The Hispanic Health Coalition of Georgia Partners with HIA Technologies to Develop HIA TOPICS

Hispanic Health Coalition of GA | June 06, 2022

On June 5th, the Hispanic Coalition of Georgia announced that it is collaborating with HIA Technologies to develop HIA TopicsTM, an education platform that will be used to address misinformation, boost engagement, and increase health literacy. The strategic expansion will address the issues of the Hispanic/Latino community as well as other minorities, underprivileged and economically challenged groups. HIA TOPICS leverages over 20 years of research in human-computer interaction, and advanced AI technologies. "The HHCGA has long regarded education as a critical strategic component in the quest to promote awareness and facilitate access to healthcare services and available benefits. By partnering with HIA, the HHCGA can now deliver a library of healthcare topics, sourced from known and respected subject matter experts to the Hispanic/Latino community. HIA TOPICS represents an extraordinary opportunity for underserved communities to have answers to health questions and to do so in an interactive virtual learning environment." Shirley E. "Bella," Borghi, HHCGA Executive Director HIA TOPICS will enable clinicians to access a physician-authored library of health topics. Digital agents will then host an interactive session that will allow patients to ask questions and get answers through a physician-controlled AI technology. The HHCGA has long regarded education as a critical strategic component in the quest to promote awareness and facilitate access to healthcare services and available benefits. By partnering with HIA, the HHCGA can now deliver a library of healthcare topics, sourced from known and respected subject matter experts to the Hispanic/Latino community. HIA TOPICS represents an extraordinary opportunity for underserved communities to have answers to health questions, and to do so in an interactive virtual learning environment." CEO Vacit Arat

Read More

HEALTH TECHNOLOGY

ZetrOZ Systems Highlights the Rise in Health Insurance Denials, Provides Solution

ZetrOZ Systems | May 30, 2022

ZetrOZ Systems, leaders in wearable medical technology and makers of the sam® wearable ultrasound device that heals soft tissue, highlighted the rising health insurance claim denials. The organization is encouraging customers to inform themselves about their healthcare policies and challenge the first denial. Millions of people in the U.S. have experienced the devastating denial of their healthcare claims. According to Change Healthcare, 11% of 102 million medical claims at 1,500 hospitals are denied at first. The rate of denials has gone up by 20% since the year 2016. "Unfortunately, medical policies are driven by insurance company profits and fear of change. Thus, patients are often denied advanced new care when they need to access their healthcare benefits for soft tissue injuries." George K. Lewis, Ph.D. and CEO of ZetrOZ Systems "The first 'no' by an insurance policy can be turned into a 'yes' if you are informed and persistent," Lewis continued. "At ZetrOZ, we encourage patients and providers to not simply give up with the first denial of an insurance claim for therapies like Sustained Acoustic Medicine (sam®). Your insurance should always cover treatments that are proven to be both medically effective and cost-effective." If a denial letter is received, consumers can appeal against the decision. Possible issues include inaccurate paperwork, incorrect billing code, misplaced tax ID or wrongly coding the prescription or procedure. Inspite of sam®’s success, it is usually not covered by the first line of treatment. The reason is often an inadequate understanding of the costs and care by patients, insurers, and insurance providers.

Read More